Anthrasil FDA Approval History
Last updated by Judith Stewart, BPharm on May 19, 2020.
FDA Approved: Yes (First approved March 24, 2015)
Brand name: Anthrasil
Generic name: Anthrax Immune Globulin Intravenous (Human)
Dosage form: Injection
Company: Emergent BioSolutions Inc.
Treatment for: Anthrax
Anthrasil [Anthrax Immune Globulin Intravenous (Human)] is an immune globulin used to treat patients with inhalational anthrax in combination with appropriate antibacterial drugs.
Development timeline for Anthrasil
|Mar 25, 2015||Approval FDA Approves Anthrasil, [Anthrax Immune Globulin Intravenous (Human)], for Inhalation Anthrax|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.